Latest KFF Health News Stories
Lo nuevo y lo que debes tener en cuenta en el próximo período de inscripción abierta de ACA
Estamos en esa época del año otra vez. En la mayoría de los estados, la temporada de inscripción abierta de la Ley de Cuidado de Salud a Bajo Precio (ACA) para los planes de salud comienza el 1 de noviembre y dura hasta el 15 de enero.
How North Carolina Made Its Hospitals Do Something About Medical Debt
State officials threatened to withhold public money from hospitals, pioneering a strategy that could become a national model.
Biden Administration Blocks Two Private Sector Enrollment Sites From ACA Marketplace
Regulators have been under the gun to curb unauthorized Obamacare enrollment and switching of plans. Separately, a pending lawsuit was amended with additional defendants and new allegations regarding tactics to garner greater ACA sales commissions.
Why Many Nonprofit (Wink, Wink) Hospitals Are Rolling in Money
Legal maneuvering, industry lobbying, and lax IRS oversight leave lots of room for “operating surpluses.”
Harris, Once Biden’s Voice on Abortion, Would Take an Outspoken Approach to Health
If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access — hitting former President Donald Trump on an issue that could undermine his chances of victory.
Pain Doesn’t Belong on a Scale of Zero to 10
A popular scale for measuring pain doesn’t work, but medicine still has no better alternative.
El dolor ya no se puede medir en una escala de cero a 10
Los médicos de hoy tienen una comprensión más completa del tratamiento del dolor, así como de las terribles consecuencias de recetar opioides con liviandad. Lo que están aprendiendo ahora es cómo medir mejor el dolor y tratar sus muchas formas.
Battleground Wisconsin: Voters Feel Nickel-and-Dimed by Health Care Costs
In the swing state of Wisconsin, the cost and availability of health care have emerged as key issues. Voters there say prescriptions, procedures, and health insurance policies are too expensive, and must be addressed by the next president, whether Republican or Democrat.
California Becomes Latest State To Try Capping Health Care Spending
California is the ninth state to set annual health spending targets for the industry. Already hospitals and doctors are voicing resistance to the fledgling Office of Health Care Affordability, even as they avoid overtly opposing its goals.
Los Angeles County Launches Ambitious Plan To Tackle Medical Debt. Hospitals Groan.
Los Angeles County, the nation’s most populous county, is spearheading a comprehensive plan to tackle a $2.9 billion medical debt crisis. Hospitals are still getting on board with the project, which is helmed by the public health department.
Biden Is Right. The US Generally Pays Double That of Other Countries for Rx Drugs.
Research has consistently found that, overall, U.S. prescription drug prices are significantly higher, sometimes two to four times as high, compared with prices in other high-income industrialized countries. However, some market factors can obscure actual prices, making comparisons harder.
With Medical Debt Burdening Millions, a Financial Regulator Steps In to Help
The Consumer Financial Protection Bureau, created after the Great Recession of 2007-09, has increasingly started policing the health care system.
Lawsuits Claim South Carolina Kids Underwent Unnecessary Genital Exams During Abuse Investigations
Lawsuits allege that several children under 18 in South Carolina have undergone examinations of their private parts during child abuse investigations — even when there were no allegations of sexual abuse. There’s a growing consensus in medicine that genital exams can be embarrassing, uncomfortable, and even traumatic.
Woman Petitions Health Insurer After Company Approves — Then Rejects — Her Infusions
Even people with good insurance aren’t guaranteed affordable care, as this KFF Health News follow-up to one patient’s saga shows.
KFF Health News' 'What the Health?': Democrats See Opportunity in GOP Threats to Repeal Health Law
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
FTC Chief Gears Up for a Showdown With Private Equity
Lina Khan, chair of the FTC, says a recent lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.
Uncle Sam Wants You … to Help Stop Insurers’ Bogus Medicare Advantage Sales Tactics
The Biden administration wants to crack down on deceptive or misleading Medicare Advantage and drug plan sales tactics. It’s counting on beneficiaries to help catch offenders.
Compensation Is Key to Fixing Primary Care Shortage
Many proposals have been floated about how to address the nation’s primary care problem. They range from training slots to medical school debt forgiveness but often sidestep comprehensive payment reform.
Why It’s So Tough to Reduce Unnecessary Medical Care
Treatments that don’t help patients, and may even harm them, are difficult to eliminate because they can be big sources of revenue.
Sin barreras, los precios de algunos medicamentos existentes se han disparado, incluso cuando han caído drásticamente en otros países. Los nuevos medicamentos tienen precios enormes, respaldados por el lobby y el marketing.
